<DOC>
	<DOC>NCT01332162</DOC>
	<brief_summary>The purpose of this study is to evaluate the benefit of the optimal pacing configuration, including the possibility of biventricular or left ventricular pacing, in hypertrophic obstructive cardiomyopathy patients.</brief_summary>
	<brief_title>CArdiac Desynchronization In Obstructive HCM, CARDIO-HCM</brief_title>
	<detailed_description>In this study, subjects will be randomized to Cardiac Resynchronization Therapy-Defibrillation (CRT-D) or Cardiac Resynchronization Therapy-Pacing (CRT-P) vs Pacing Therapy AAI. Randomization will be stratified by indication. Optimal pharmacological therapy in both treatment arms. Length of follow-up for each subject will be 2y, since all subjects will be followed to a common study termination date.</detailed_description>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Cardiomyopathy, Hypertrophic</mesh_term>
	<criteria>Patients with hypertrophic Obstructive Cardiomyopathy with significant left ventricular obstruction (baseline LVOT gradient more 50mmHg and severe symptoms HOCM intraventricular gradient &lt; 50mmHg LV ejection fraction &lt; 50% mild symptoms</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Hypertrophic Obstructive Cardiomyopathy (HOCM)</keyword>
	<keyword>Pacing</keyword>
</DOC>